ROVAMYCINE 250 CAPSULE 750000 UNIT DIN 01927825
Health Canada record
| Active ingredient(s) | SPIRAMYCIN 750000 UNIT |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA02 SPIRAMYCIN |
| Original market date | 31-Dec-1957 |
| Current status date | 20-Jun-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Odan Laboratories Ltd. — licence 100025, currently licensed, last inspection rating C (2024-03-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SPIRAMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01927817 | ROVAMYCINE 500 CAPSULE 1500000 UNIT | ODAN LABORATORIESLTD | Capsule | SPIRAMYCIN 1500000 UNIT | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 5912 | 2004-11-14 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 1469 | 2000-11-01 | New Drug Submission (NDS) |
International API supply for SPIRAMYCIN
3 valid EDQM Certificates of Suitability from 3 holders. 0 active FDA Drug Master Files.
Request a quote for ROVAMYCINE 250 CAPSULE 750000 UNIT